Other Announcements

Date Description PDF File
16/03/2018 HealthFore informed BSE that Mr. Amit Gupta, Chief Financial Officer of the Company, has resigned from the Company with effect from March 15, 2018.
15/03/2018 HealthFore informed BSE that Mr. Rama Krishna Shetty, has resigned from the Board of Directors of the Company with effect from March 14, 2018.
14/03/2018 HealthFore informed BSE that Mr. Atul Mandahar, has resigned from the Board of Directors of the Company with effect from March 13, 2018.
05/03/2018 HealthFore informed BSE that Mr. Daljit Singh, has resigned from the Board of Directors of the Company with effect from March 02, 2018.
05/03/2018 HealthFore informed BSE that Mr. Varun Sood, Managing Director of the Company, has resigned from the Board of Directors of the Company with effect from March 01, 2018.
17/02/2018 HealthFore informed BSE that Mr. Harjiv Singh has resigned from the Board of Directors of the Company with effect from February 16, 2018.
08/02/2018 HealthFore informed BSE that Mr. Nalin Nayyar has resigned from the Board of Directors of the Company with effect from February 08, 2018.
05/02/2018 HealthFore informed BSE that Ms. Kalpana Sinha has vacated the office of Director of the Company w.e.f. December 01, 2017.
16/01/2018 HealthFore informed BSE that Mr. Hemant Dhingra has resigned from the Board of Directors of the Company with effect from January 16, 2018.
17/11/2017 Resignation of Mr. Vivek Kumar Singh
01/11/2017 Appointment of Mr. Vivek Kumar Singh as Company Secretary and Compliance Officer
25/09/2017 Voting results for 8th Annual General Meeting
22/09/2017 Outcome of 8th Annual General Meeting
30/08/2017 Shifting of Registered office of the Company
06/06/2017 Shifting of Registered office of the Company
01/06/2017 Resignation of Shikha Rastogi.
02/05/2017 HealthFore informed BSE that Mr. Varun Sood has resigned from the position of Chief Executive Officer of the Company with effect from May 01, 2017.
HealthFore further informed BSE that Mr. Varun Sood has been appointed as Managing Director of the Company with effect from May 02, 2017 for a period of three years subject to the approval of the Shareholders of the Company. He has also been designated as a Key Managerial Personnel of the Company under the Companies Act, 2013.
27/01/2016 HealthFore informed BSE that M/s. RRCA & Associates (Firm Registration No. 022107N), Statutory Auditors of the Company have intimated the Company that M/s. RRCA & Associates have merged with M/s. Ravi Rajan & Co. (Firm Registration No. 009073N), Chartered Accountants w.e.f. December 01, 2015.
06/01/2016 HealthFore informed BSE that Mr. Maninder Singh Grewal has resigned from the Board of Directors of the Company with effect from January 06, 2016.
15/12/2015 HealthFore informed BSE about details relating to Scheme of Amalgamation between Oscar Investments Limited and the Company as required under Regulation 30(2) of the SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 and Policy for Determination of Materiality of Event and Information of the Company.
14/12/2015 HealthFore informed BSE that based on the recommendation of the Audit Committee, the Board of Directors of HealthFore Technologies Limited ("the Company") at their meeting held today have inter-alia, considered and approved the scheme of Amalgamation under Section 391 to 394 of the Companies Act, 1956 and corresponding sections of the Companies Act, 2013 (as and when such corresponding sections are notified in the Official Gazette by the Central Government) between Oscar Investments Limited ('Amalgamated Company') and HealthFore Technologies Limited ('HTL' or 'Amalgamating Company') and their respective shareholders and creditors ('Scheme').

The proposed amalgamation will provide financial strength to the Amalgamating Company to invest in the growth of its Healthcare IT business. The proposed Amalgamation would further build a stronger and sustainable business and enhance the potential for future growth. It will strengthen the competitive position of the combined entity and would result in increased shareholders value of both the companies.

The proposed Scheme would be subject to approvals of Delhi High Court, Stock Exchange, Shareholders and Creditors, Statutory and other Regulatory Approvals, if any.
27/10/2015 HealthFore informed BSE regarding resignation of Mr. Maninder Singh Grewal from the position of Managing Director and Key Managerial Personnel of the Company, effective from close of business hours on December 31, 2015. However, he will continue to act as Director and Non-executive Chairman of the Board of Directors of the Company w.e.f January 1, 2016.

Further, Mr. Varun Sood has been appointed as Chief Executive Officer of the Company and designating him as one of the Key Managerial Personnel, effective from January 1, 2016.
21/05/2015 HealthFore informed BSE that Mr. Vikram Sahgal has resigned from the Board of Directors of the Company with effect from May 21, 2015.

Further, Mr. Harjiv Singh has been appointed as an Independent Non-Executive Director on the Board of the Company with effect from May 21, 2015.
24/03/2015 HealthFore informed BSE that Mr. Harpal Singh and Mr. Padam Narain Bahl have resigned as member of the Board of the Company with effect from March 24, 2015.

Further, Mr. Hemant Dhingra has been appointed as a Non-Executive Non-Independent Director on the Board of the Company with effect from March 24, 2015.
10/02/2015 HealthFore informed BSE that Mr. Shivinder Mohan Singh, Non-Executive Director, has resigned from the Board of Directors of the Company with effect from February 10, 2015
07/07/2014 HealthFore informed BSE that Dr. P. S. Joshi has resigned as a member of the Board of the Company with effect from July 04, 2014.

Further, Mr. Atul Mandahar has been appointed as an Independent Non-Executive Director on the Board of the Company with effect from July 07, 2014.
03/07/2014 HealthFore informed BSE that Mr. Sunil Godhwani and Capt. G.P.S. Bhalla have resigned as member of the Board of the Company with effect from July 03, 2014.